Neuropsychiatric Toxicity Associated With Cytokine Therapies
- 31 October 1999
- journal article
- review article
- Published by Elsevier in Psychosomatics
- Vol. 40 (5) , 428-435
- https://doi.org/10.1016/s0033-3182(99)71208-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancerCancer, 1998
- Multiple cerebral lesions complicating therapy with interleukin-2Neurology, 1996
- Interleukin-2 as a neuroregulatory cytokineBrain Research Reviews, 1995
- Neurological and Psychiatric Adverse Effects of Immunological TherapyCNS Drugs, 1995
- Neurotoxicity of antitumoral IL-2 therapy: Evoked cognitive potentials and brain mappingThe Italian Journal of Neurological Sciences, 1994
- A Comparison of 2 Modes of Administration of Recombinant Interleukin-2: Continuous Intravenous Infusion Alone Versus Subcutaneous Administration plus Interferon Alpha in Patients with Advanced Renal Cell Carcinoma.Cancer Biotherapy, 1993
- Clinical Toxicity of Interleukin-2Drug Safety, 1992
- The Neuroendocrine Effects of Interleukin-2 TreatmentJournal of Clinical Endocrinology & Metabolism, 1989
- The effect of intravenous interleukin-2 on brain water contentJournal of Neurosurgery, 1989
- The Neuropsychiatric Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer CellsAnnals of Internal Medicine, 1987